The PE Ratio as of December 2025 (TTM) for Syncom Formulations (India) Limited (SYNCOMF.NS) is 23.29

According to Syncom Formulations (India) Limited’s latest financial reports and current stock price. The company's current PE Ratio is 23.29. This represents a change of -22.00% compared to the average of 29.86 of the last 4 quarters.

Syncom Formulations (India) Limited (SYNCOMF.NS) Historical PE Ratio (quarterly & annually)

How has SYNCOMF.NS PE Ratio performed in the past?

The mean historical PE Ratio of Syncom Formulations (India) Limited over the last ten years is 44.61. The current 23.29 PE Ratio has changed 5.12% with respect to the historical average. Over the past ten years (40 quarters), SYNCOMF.NS's PE Ratio was at its highest in in the March 2015 quarter at 91.70. The PE Ratio was at its lowest in in the December 2020 quarter at 15.58.

Syncom Formulations (India) Limited (SYNCOMF.NS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Syncom Formulations (India) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syncom Formulations (India) Limited (SYNCOMF.NS) Average PE Ratio

How has SYNCOMF.NS PE Ratio performed in the past?

The current PE Ratio of Syncom Formulations (India) Limited (SYNCOMF.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Syncom Formulations (India) Limited (SYNCOMF.NS) PE Ratio vs. Peers

How is SYNCOMF.NS’s PE Ratio compared to its peers?

Syncom Formulations (India) Limited’s PE Ratio is greater than Jagsonpal Pharmaceuticals Limited (22.50), less than Bajaj HealthCare Limited (28.91), greater than Jagsonpal Pharmaceuticals Limited (22.50), less than Bajaj HealthCare Limited (28.91), greater than Bliss GVS Pharma Limited (16.50), greater than Bliss GVS Pharma Limited (16.50), greater than Megasoft Limited (10.58), less than Hester Biosciences Limited (35.57), less than Hester Biosciences Limited (35.57), greater than TTK Healthcare Limited (23.17),

Build a custom stock screener for Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syncom Formulations (India) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syncom Formulations (India) Limited (SYNCOMF.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syncom Formulations (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.